Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults (Lifestyles)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01142349
Recruitment Status : Completed
First Posted : June 11, 2010
Last Update Posted : December 19, 2013
Sponsor:
Collaborator:
Kaiser Permanente
Information provided by (Responsible Party):
Michael Vitiello, University of Washington

Brief Summary:
This study compares the efficacy of three group interventions for people with co-morbid osteoarthritis (OA) and insomnia to help them manage their OA symptoms. The investigators hypothesize that a combination cognitive-behavioral treatment will produce significantly greater initial and long-term improvements in OA symptoms than will the other two treatments.

Condition or disease Intervention/treatment Phase
Pain Dysfunction Sleep Disturbance Osteoarthritis Behavioral: Lifestyles A Behavioral: Lifestyles B Behavioral: Lifestyles C Not Applicable

Detailed Description:
This study is only for members of the Group Health Cooperative (GHC) of Puget Sound who have both osteoarthritis pain and insomnia. The first part of the study involves filling out a mailed survey. Based on the results of the survey some respondents will be eligible for the second part of the study. Our goal in the second part is to test three different treatments for managing OA symptoms. The programs teach about things people with arthritis can do to improve the quality of their lives. All three programs deal with pain, sleep, mood and activity-but each has a slightly different focus. Participants will be randomly assigned to one of the three programs. Each program is made up of six weekly group sessions that last about 90-120 minutes. The programs will be co-led by licensed therapists and each will include 8-12 members. Study participants will also take part in a series of visits at their homes over the next 18 months. At each visit the investigators will ask them to do a few other study activities, such as keep a 7-day diary of their sleep and fill out a survey about their arthritis pain. With their permission the investigators will also ask them to let us collect some information from their GHC medical records.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 367 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults
Study Start Date : January 2009
Actual Primary Completion Date : August 2013
Actual Study Completion Date : August 2013

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Lifestyles A
Cognitive Behavioral Therapy for Pain and Insomnia
Behavioral: Lifestyles A
Six weekly group sessions that last about 90-120 minutes presenting cognitive behavioral therapy for pain and insomnia

Experimental: Lifestyle B
Cognitive Behavioral Therapy for Pain
Behavioral: Lifestyles B
Six weekly group sessions that last about 90-120 minutes presenting cognitive behavioral therapy for pain.

Active Comparator: Lifestyles C
Osteoarthritis Education
Behavioral: Lifestyles C
Six weekly group sessions that last about 90-120 minutes presenting osteoarthritis education.




Primary Outcome Measures :
  1. Insomnia Severity Index (ISI) [ Time Frame: Baseline ]
    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  2. Insomnia Severity Index (ISI) [ Time Frame: Post treatment- 2 months post baseline assessment ]
    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  3. Insomnia Severity Index (ISI) [ Time Frame: 9 months post baseline assessment ]
    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  4. Insomnia Severity Index (ISI) [ Time Frame: 18 months post baseline assessment ]
    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  5. Global Pain Severity-Graded Chronic Pain Scale [ Time Frame: Baseline ]
    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

  6. Global Pain Severity-Graded Chronic Pain Scale [ Time Frame: Post treatment-2 mos. post baseline ]
    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

  7. Global Pain Severity-Graded Chronic Pain Scale [ Time Frame: 9 months post baseline assessment ]
    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

  8. Global Pain Severity- Graded Chronic Pain Scale [ Time Frame: 18 months post baseline assessment ]
    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 60+
  • Continuously enrolled in Group Health one year prior to sample pull
  • Primary care clinic at selected clinics
  • Not in "No Contact File"
  • Diagnosis 715xx (Osteoarthritis) in prior three years

Exclusion Criteria:

  • Not continuously enrolled in Group Health for at least one year
  • Medical record information indicates a diagnosis of:

    1. rheumatoid arthritis
    2. obstructive sleep apnea
    3. periodic leg movement disorder
    4. restless leg syndrome
    5. sleep-wake cycle disturbance
    6. rapid eye movement (REM) behavior disorder
    7. dementia or receiving cholinesterase inhibitors
    8. Parkinson's disease or other neurodegenerative disease known to directly impact sleep
    9. cancer in the past year and receiving chemotherapy or radiation therapy in the past year
    10. inpatient treatment for congestive heart failure within the previous 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01142349


Locations
Layout table for location information
United States, Washington
Group Health Research Institute
Seattle, Washington, United States, 98101
University of Washington
Seattle, Washington, United States, 98115
Sponsors and Collaborators
University of Washington
Kaiser Permanente
Investigators
Layout table for investigator information
Principal Investigator: Michael V Vitiello, Ph.D. University of Washington
Principal Investigator: Susan M McCurry, Ph.D. University of Washington
Principal Investigator: Michael Von Korff, Sc.D. Group Health Research Institute
Principal Investigator: Ben Balderson, Ph.D. Group Health Research Institute
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Michael Vitiello, Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01142349    
Other Study ID Numbers: R01AG031126 ( U.S. NIH Grant/Contract )
R01AG031126 ( U.S. NIH Grant/Contract )
First Posted: June 11, 2010    Key Record Dates
Last Update Posted: December 19, 2013
Last Verified: December 2013
Keywords provided by Michael Vitiello, University of Washington:
Arthritis
Group Program
Pain
Insomnia
Pain dysfunction and sleep disturbance among older adults with osteoarthritis.
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis
Osteoarthritis
Sleep Initiation and Maintenance Disorders
Dyssomnias
Parasomnias
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases
Mental Disorders